Author:
Abbott William G.H.,Geursen Arie,Fraser John D.,Skinner Margot A.,Tan Paul L.J.,Marbrook John
Subject
Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine
Reference23 articles.
1. Antibodies to a synthetic peptide from the pre-S 120–145 region of the hepatitis B virus envelope are virus neutralising;Neurath;Vaccine,1986
2. Immunity to hepatitis B: analysis of antibody and cellular responses in recipients of a plasma derived vaccine using synthetic peptides mimicking S and pre-S regions;Steward;Clin. Exp. Immunol.,1988
3. Recognition of hepatitis B surface antigen by human T lymphocytes;Celis;J. Immunol.,1988
4. Hepatitis B Vaccine. Demonstration of efficacy in a controlled clinical trial in a high risk population;Szmuness;N. Engl. J. Med.,1980
5. Long term immunogenicity and efficacy of hepatitis B vaccine in infants born to HBeAg positive HBsAg carrier mothers;Lo;Hepatology,1988